Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49K Hold
407
0.02% 120
2025
Q4
$43K Hold
407
0.02% 119
2025
Q3
$34K Hold
407
0.02% 126
2025
Q2
$32K Hold
407
0.02% 156
2025
Q1
$37K Sell
407
-10,007
-96% -$934K 0.02% 123
2024
Q4
$1.04M Buy
10,414
+9,938
+2,088% +$1.02M 0.49% 22
2024
Q3
$54K Sell
476
-60
-11% -$7.13K 0.03% 124
2024
Q2
$66K Sell
536
-74
-12% -$9.53K 0.03% 113
2024
Q1
$80K Hold
610
0.04% 119
2023
Q4
$67K Sell
610
-1,003
-62% -$104K 0.03% 120
2023
Q3
$166K Sell
1,613
-131
-8% -$14.1K 0.11% 51
2023
Q2
$201K Buy
1,744
+1,306
+298% +$148K 0.13% 34
2023
Q1
$47K Hold
438
0.03% 91
2022
Q4
$49K Buy
+438
New +$44.8K 0.03% 123
2020
Q3
$36K Buy
459
+40
+10% +$3.13K 0.05% 165
2020
Q2
$31K Hold
419
0.03% 172
2020
Q1
$31K Sell
419
-3,354
-89% -$264K 0.05% 189
2019
Q4
$327K Buy
+3,773
New +$310K 0.31% 90

Other funds holding MRK

Horizon Bancorp's MRK Position: Q1 2026 in Review

Horizon Bancorp held its Merck (MRK) position steady in Q1 2026 at 407 shares worth $49K. The position accounts for 0.02% of the portfolio, ranked #120.

Horizon Bancorp first reported a position in MRK in Q4 2019 and has held it in 18 quarters since. The position peaked at $1.04M in Q4 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Horizon Bancorp held 407 shares of Merck worth $49K as of Q1 2026.
  • Horizon Bancorp left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.02% of Horizon Bancorp's portfolio in Q1 2026, its #120 holding.
  • Horizon Bancorp first reported a position in Merck in Q4 2019 and has held it in 18 quarters since.
  • Horizon Bancorp's Merck position peaked at $1.04M in Q4 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.